| Income Statement |
| Total Revenue | 8.50M |
|
| Revenues (USD) | 8.50M |
| Cost of Revenue | 1.23M |
| Gross Profit | 7.27M |
| Operating Expenses | 2.34M |
| Research and Development Expense | 151.38K |
| Selling, General and Administrative Expense | 1.10M |
| Operating Income | 4.93M |
| Interest Expense | 710.48K |
| Net Income | 4.21M |
| Net Income Common Stock | 4.21M |
| Net Income Common Stock (USD) | 4.21M |
| Consolidated Income | 4.21M |
| Earnings per Basic Share | 1.32 |
| Earnings per Basic Share (USD) | 1.32 |
| Earnings per Diluted Share | 1.32 |
| Earning Before Interest & Taxes (EBIT) | 4.92M |
| Earning Before Interest & Taxes (USD) | 4.92M |
| Weighted Average Shares | 3.19M |
| Weighted Average Shares Diluted | 3.19M |
| Balance Sheet |
| Cash and Equivalents | 675.95K |
| Cash and Equivalents (USD) | 675.95K |
| Investments | 103.68K |
| Investments Current | 62.68K |
| Investments Non-Current | 41.00K |
| Trade and Non-Trade Receivables | 71.87K |
| Current Assets | 24.69M |
| Property, Plant & Equipment Net | 5.63M |
| Total Assets | 30.76M |
| Debt Current | 8.75M |
| Total Debt | 21.96M |
| Current Liabilities | 18.92M |
| Debt Non-Current | 13.22M |
| Total Liabilities | 33.92M |
| Accumulated Retained Earnings (Deficit) | -100.90M |
| Accumulated Other Comprehensive Income | 67.10K |
| Shareholders Equity | -3.16M |
| Shareholders Equity (USD) | -3.16M |
| Assets Non-Current | 6.08M |
| Total Debt (USD) | 21.96M |
| Deferred Revenue | 5.17M |
| Inventory | 23.65M |
| Liabilities Non-Current | 15.00M |
| Trade and Non-Trade Payables | 4.08M |
| Cash Flow |
| Depreciation, Amortization & Accretion | 339.26K |
| Net Cash Flow from Financing | 1.42M |
| Net Cash Flow / Change in Cash & Cash Equivalents | 164.86K |
| Issuance (Repayment) of Debt Securities | 467.32K |
| Net Cash Flow from Operations | -1.21M |
| Effect of Exchange Rate Changes on Cash | -41.55K |
| Share Based Compensation | 50.88K |